Endothelial and inflammatory markers in relation to progression of ischaemic cerebral small-vessel disease and cognitive impairment: A 6-year longitudinal study in patients with type 2 diabetes mellitus

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 11, 2011, Pages 1186-1194

  Umemura, Toshitaka ^a   Kawamura, T ^a   Umegaki, H ^b   Mashita, S ^a   Kanai, A ^a   Sakakibara, T ^a   Hotta, N ^a   Sobue, G ^b  

^a CHUBU ROSAI HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; AGE; AGED; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN RADIOGRAPHY; BRAIN REGION; CEREBROVASCULAR DISEASE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE MARKER; FEMALE; GENDER; HUMAN; HYPERTENSION; INFLAMMATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VASCULAR ENDOTHELIUM; WHITE MATTER;

EID: 80053619327     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2010.217380     Document Type: Article

References (40)

1. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 2007;6:611-19. (Pubitemid 46921055)
2. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010;341:c3666.
3. Vermeer SE, Hollander M, van Dijk EJ, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003;34:1126-9. (Pubitemid 36547501)
4. Kobayashi S, Okada K, Koide H, et al. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 1997;28:1932-9. (Pubitemid 27458998)
5. Vermeer SE, den Heijer T, Koudstaal PJ, et al. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2003;34:392-6. (Pubitemid 36206336)
6. van Harten B, Scheltens P, de Leeuw FE, et al. Brain imaging in patients with diabetes: a systematic review. Diabetes Care 2006;29:2539-48. (Pubitemid 44912267)
7. van Harten B, Oosterman JM, Potter van Loon BJ, et al. Brain lesions on MRI in elderly patients with type 2 diabetes mellitus. Eur Neurol 2007;57:70-4.
8. Gouw AA, van der Flier WM, Fazekas F, et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke 2008;39:1414-20.
9. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003;170:191-203. (Pubitemid 37377790)
10. Kawamura T, Umemura T, Kanai A, et al. The incidence and characteristics of silent cerebral infarction in elderly diabetic patients: association with serum soluble adhesion molecules. Diabetologia 1998;41:911-17. (Pubitemid 28365977)
11. Kawamura T, Umemura T, Kanai A, et al. Soluble adhesion molecules and C-reactive protein in the progression of silent cerebral infarction in patients with type 2 diabetes mellitus. Metabolism 2006;55:461-6.
12. Rost NS, Wolf PA, Kase CS, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham Study. Stroke 2001;32:2575-9. (Pubitemid 33055308)
13. Ishikawa J, Tamura Y, Hoshide S, et al. Low-grade inflammation is a risk factor for clinical stroke events in addition to silent cerebral infarcts in Japanese older hypertensives: the Jichi Medical School ABPM Study, wave 1. Stroke 2007;38:911-17. (Pubitemid 46568452)
14. Kanai A, Kawamura T, Umemura T, et al. Association between future events of brain infarction and soluble levels of intercellular adhesion molecule-1 and C-reactive protein in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2008;82:157-64.
15. van Dijk EJ, Prins ND, Vermeer SE, et al. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 2005;112:900-5. (Pubitemid 41170078)
16. Wada M, Nagasawa H, Kurita K, et al. Cerebral small vessel disease and C-reactive protein: Results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci 2008;264:43-9. (Pubitemid 350184068)
17. Engelhart MJ, Geerlings MI, Meijer J, et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam Study. Arch Neurol 2004;61:668-72. (Pubitemid 38637682)
18. Dik MG, Jonker C, Hack CE, et al. Serum inflammatory proteins and cognitive decline in order persons. Neurology 2005;64:1371-7. (Pubitemid 40570504)
19. Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 2005;48:2460-9. (Pubitemid 41738208)
20. van den Berg E, Reijmer YD, de Bresser J, et al; On behalf of the Utrecht Diabetic Encephalopathy Study Group. A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia 2010;53:58-65.
21. Fazekas F, Chawluk J, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentogenol 1987;149:351-6. (Pubitemid 17104996)
22. Prins ND, van Straaten EC, van Dijk EJ, et al. Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics. Neurology 2004;62:1533-9. (Pubitemid 38608191)
23. Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992;40:922-35.
24. Mogi N, Umegaki H, Hattori A, et al. Cognitive function in Japaneae elderly with type 2 diabetes mellitus. J Diabetes Complications 2004;18:42-6. (Pubitemid 38332950)
25. Mohs RC, Rosen WG, Davis KL. The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. Psychophrmacol Bull 1983;19:448-50. (Pubitemid 13041813)
26. Wechsler D. The Wechsler Adult Intelligence Scale - Revised. New York: The Psychological Corporation, 1981.
27. Stoop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643-62.
28. Umemura T, Kawamura T, Sakakibara T, et al. Association of soluble adhesion molecule and C-reactive protein levels with silent brain infarction in patients with and without type 2 diabetes. Curr Neurovasc Res 2008;5:106-11. (Pubitemid 351838575)
29. Fassbender K, Bertsch T, Mielke O, et al. Adhesion molecules in cerebrovascular disease. Evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease. Stroke 1999;30:1647-50. (Pubitemid 29379618)
30. Hassan A, Hunt BJ, O'Sullivan M, et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003;126:424-32. (Pubitemid 36172746)
31. Markus HS, Hunt B, Palmer K, et al. Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities. Longitudinal results of the Austrian Stroke Prevention Study. Stroke 2005;36:1410-14. (Pubitemid 40967503)
32. Wardlaw JM, Sandercock PA, Dennis MS, et al. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 2003;34:806-12.
33. Hoshi T, Kitagawa K, Yamagami H, et al. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 2005;36:768-72.
34. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-22. (Pubitemid 36359297)
35. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005;128:2034-41. (Pubitemid 41253271)
36. de Groot JC, de Leeuw FE, Oudlkerk M, et al. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol 2002;52:335-41.
37. van Dijk EJ, Prins ND, Vrooman HA, et al. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences. Rotterdam Scan Study. Stroke 2008;39:2712-19.
38. Schmidt R, Petrovic K, Ropele S, et al. Progression of leukoaraiosis and cognition. Stroke 2007;38:2619-25. (Pubitemid 47329648)
39. Biessels GJ, Staekenborg S, Brunner E, et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006;5:64-74. (Pubitemid 41790697)
40. Sonnen JA, Larson EB, Brickell K, et al. Different patterns of cerebral injury in dementia with or without diabetes. Arch Neurol 2009;66:315-22.